Shorts

Navigating Financial Complexity of Advanced Therapies: A Role for Specialty Pharmacy

Coordinating Care When Every Minute Matters

Building the Foundation for Advanced Therapy Delivery in the Community

180 Advanced Therapies by 2030—Are Clinicians Ready?

BRIDGE: An Integrated Platform for Early-Onset Cancer Research and Care

National Study Affirms Value of Community Oncology

Bridging Oncology Silos to Improve Early-Onset Cancer Care

How Genome Sequencing Changed Cancer Research

Is Knowing Too Much About Your DNA Actually Dangerous?

From Generic to Personalized Cancer Care in Hours

A New Early-Onset Cancer Program Is Coordinating Fragmented Care

Why Early-Onset Cancer Cases Deserve Attention

Can Engineering Stem Cells to Prevent GVHD Save Health Systems Money?

60% of Early-Onset Cancers May Be Screenable

Does Weight Change How Cancer Cells Behave?

One Child Cured Equals Decades of Life Saved

A Powerful New Way to Measure Cancer Success

A Promising Breakthrough in Platinum-Resistant Ovarian Cancer Survival

IMNN-001: A Broader Approach to Immunotherapy

Cultivating A Culture of Clinical Trials in Pediatrics

Dr Wang on Managing Post-CAR T Infections: Act Fast and Coordinate Care

Why Children Are Not Just ‘Little Adults’ in Cancer Treatment

Dr Wang: Check IgG Early to Prevent Infections After CAR T

Closing the Gap Between Immunotherapy Innovation and Outdated Evaluation Standards

Dr Thaker Highlights Personalized PARP Strategies and the Promise of IMNN-001 in Ovarian Cancer

Giving Patients the Power to Choose

ROSELLA Shows Survival Benefit With Convenient Relacorilant Dosing

BTK Degraders: A New Hope for Resistant CLL

A New Alternative to Phlebotomy

Promising Responses in Ewing Sarcoma Trial